Forte Biosciences, Inc.

This study tests a new medicine called FB102 for people with severe to very severe alopecia areata, a condition causing major hair loss. About 32 adults will receive either FB102 or a placebo to see if it is safe and helps hair grow back. The main goal is to check for side effect…

This study tests an experimental drug called FB102 in 100 adults with well-controlled celiac disease who follow a strict gluten-free diet. Participants will receive either the drug or a placebo and then undergo a controlled gluten challenge to see if FB102 can reduce intestinal d…

This early-stage trial tests a new medicine called FB102 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The study will include 64 adults and aims to see if the drug is safe and can help bring back skin color on the face. Participants wi…